JP2022551813A5 - - Google Patents

Info

Publication number
JP2022551813A5
JP2022551813A5 JP2022515099A JP2022515099A JP2022551813A5 JP 2022551813 A5 JP2022551813 A5 JP 2022551813A5 JP 2022515099 A JP2022515099 A JP 2022515099A JP 2022515099 A JP2022515099 A JP 2022515099A JP 2022551813 A5 JP2022551813 A5 JP 2022551813A5
Authority
JP
Japan
Prior art keywords
peptide
hrc
antiviral
complex according
peptide complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022515099A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551813A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/049473 external-priority patent/WO2021046398A2/en
Publication of JP2022551813A publication Critical patent/JP2022551813A/ja
Publication of JP2022551813A5 publication Critical patent/JP2022551813A5/ja
Pending legal-status Critical Current

Links

JP2022515099A 2019-09-04 2020-09-04 麻疹に対する併用抗ウイルス療法 Pending JP2022551813A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962895752P 2019-09-04 2019-09-04
US62/895,752 2019-09-04
US202062988286P 2020-03-11 2020-03-11
US62/988,286 2020-03-11
US202063009883P 2020-04-14 2020-04-14
US63/009,883 2020-04-14
PCT/US2020/049473 WO2021046398A2 (en) 2019-09-04 2020-09-04 Combination antiviral therapy for measles

Publications (2)

Publication Number Publication Date
JP2022551813A JP2022551813A (ja) 2022-12-14
JP2022551813A5 true JP2022551813A5 (https=) 2023-09-13

Family

ID=74853434

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022515099A Pending JP2022551813A (ja) 2019-09-04 2020-09-04 麻疹に対する併用抗ウイルス療法

Country Status (6)

Country Link
US (1) US20230014151A1 (https=)
EP (1) EP4025586A4 (https=)
JP (1) JP2022551813A (https=)
CN (1) CN114729007A (https=)
IL (1) IL291091A (https=)
WO (1) WO2021046398A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022159372A1 (en) * 2021-01-22 2022-07-28 Decoy Therapeutics, Inc. Methods and compositions for treating infections
WO2023150375A2 (en) * 2022-02-07 2023-08-10 Decoy Therapeutics Inc. Methods and compositions for treating covid infections
WO2025085916A1 (en) * 2023-10-20 2025-04-24 The Trustees Of Columbia University In The City Of New York Humanized monoclonal antibody and vaccines against measles virus
WO2025111546A1 (en) * 2023-11-22 2025-05-30 Board Of Trustees Of Michigan State University Development of broad-spectrum anti-opioid vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2372633T3 (es) * 2003-11-04 2012-01-25 The Administrators Of The Tulane Educational Fund Procedimiento de evitar condensación de virus: células inhibiendo la función de la región de iniciación de condensación en los virus arn que tienen proteínas de envoltura fusogénicas de membrana de clase i.
CA2687700A1 (en) * 2007-05-16 2008-11-27 Conjuchem Biotechnologies Inc. Cysteic acid derivatives of anti-viral peptides
EP2603241A2 (en) * 2010-08-11 2013-06-19 Jv Bio Srl Multimeric inhibitors of viral fusion and uses thereof
WO2015171924A2 (en) * 2014-05-07 2015-11-12 Cornell University Inhibitors of fusion between viral and cell membranes as well as compositions and methods of using them

Similar Documents

Publication Publication Date Title
JP2022551813A5 (https=)
US10259848B2 (en) Compositions and methods comprising hydrocarbon-stapled polypeptides
CN101415723B (zh) 具有改良生物学特性的hiv融合抑制肽
US20230399364A1 (en) Immunogenic Coronavirus Fusion Proteins and Related Methods
EP4458844A1 (en) Anti-coronavirus polypeptide, and derivatives thereof and application thereof
WO2021207848A1 (en) Mers-cov vaccine
EP1620061B1 (en) Antiviral agents for the treatment, control and prevention of infections by coronaviruses
EP1797112B1 (en) Inhibitors of hepatitits c virus
CN101874038A (zh) 治疗性抗-hiv肽的合成方法
WO2021164576A1 (zh) 用于抗冠状病毒感染的药物及其应用
US20030219451A1 (en) Stable helical C peptides and uses therefor
WO2023143619A1 (zh) 一种阻断病毒侵染细胞的中和阻断剂及其制备方法和应用
ZA200509512B (en) Antiviral agents for the treatment, control and prevention of infections by coronaviruses
WO2024130061A1 (en) Immunogenic ebolavirus fusion proteins and related methods
WO2024059149A2 (en) Immunogenic coronavirus fusion proteins and related methods
HK40118032A (zh) 可抑制类mers冠状病毒感染的多肽及其应用
JP4188897B2 (ja) ウィルス感染・増殖抑制剤
EP1500662A2 (en) Stabilizing peptides